Measures antibodies (IgG/IgM/IgA) against cardiolipin, a lipid‑binding target involved in clotting. Persistent positives can be associated with higher risk of abnormal clots.
Used when there are unexplained blood clots, stroke at a young age, or recurrent pregnancy loss to assess for antiphospholipid syndrome (APS).